Showing 1 - 8 results of 8 for search 'Jose Luis Izquierdo-Garcia', query time: 0.03s
Refine Results
-
1
-
2
Editorial: Metabolic changes in vascular disorders: A path for early diagnosis and new therapeutic targets by Sana Ayyoub, Isabel Blanco, Isabel Blanco, José Luis Izquierdo-García, José Luis Izquierdo-García, José Luis Izquierdo-García, Olga Tura-Ceide, Olga Tura-Ceide, Olga Tura-Ceide
Published 2023-03-01
Article -
3
A comparative NMR-based metabolomics study of lung parenchyma of severe COVID-19 patients by Joaquín I. Hurtado, Andrés López-Radcenco, José Luis Izquierdo-García, José Luis Izquierdo-García, José Luis Izquierdo-García, Fernando Rodríguez, Guillermo Moyna, Gonzalo Greif, Nicolás Nin, Nicolás Nin
Published 2023-11-01
Article -
4
Benchtop NMR-Based Metabolomics: First Steps for Biomedical Application by Pilar Alonso-Moreno, Ignacio Rodriguez, Jose Luis Izquierdo-Garcia
Published 2023-04-01
Article -
5
Further Advances in Atrial Fibrillation Research: A Metabolomic Perspective by Laura Arbeloa-Gómez, Jaime Álvarez-Vidal, Jose Luis Izquierdo-García
Published 2022-03-01
Article -
6
-
7
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat mode... by Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Jose Luis Izquierdo-García, Jose Luis Izquierdo-García, Jose Luis Izquierdo-García, Bianca Barreira, Bianca Barreira, Bianca Barreira, Sergio Esquivel-Ruiz, Sergio Esquivel-Ruiz, Sergio Esquivel-Ruiz, Maria Callejo, Maria Callejo, Maria Callejo, Rachele Pandolfi, Rachele Pandolfi, Rachele Pandolfi, Palmira Villa-Valverde, Palmira Villa-Valverde, Ignacio Rodríguez, Ignacio Rodríguez, Angel Cogolludo, Angel Cogolludo, Angel Cogolludo, Jesus Ruiz-Cabello, Jesus Ruiz-Cabello, Jesus Ruiz-Cabello, Francisco Perez-Vizcaino, Francisco Perez-Vizcaino, Francisco Perez-Vizcaino, Laura Moreno, Laura Moreno, Laura Moreno
Published 2023-06-01
Article -
8
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model by Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Jose Luis Izquierdo-García, Jose Luis Izquierdo-García, Jose Luis Izquierdo-García, Bianca Barreira, Bianca Barreira, Bianca Barreira, Sergio Esquivel-Ruiz, Sergio Esquivel-Ruiz, Sergio Esquivel-Ruiz, Maria Callejo, Maria Callejo, Maria Callejo, Rachele Pandolfi, Rachele Pandolfi, Rachele Pandolfi, Palmira Villa-Valverde, Palmira Villa-Valverde, Ignacio Rodríguez, Ignacio Rodríguez, Angel Cogolludo, Angel Cogolludo, Angel Cogolludo, Jesus Ruiz-Cabello, Jesus Ruiz-Cabello, Jesus Ruiz-Cabello, Francisco Perez-Vizcaino, Francisco Perez-Vizcaino, Francisco Perez-Vizcaino, Laura Moreno, Laura Moreno, Laura Moreno
Published 2023-03-01
Article